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Our study shows that the secretion of a major non-glycosylated, phosphoprotein of 69 kDa (pp69) is a spe- 
cific marker for non-transformed NRK-49F ceils. Treatment of NRK-49F cells with EGF alone or with 
different combinations ofEGF plus TGF-fl modulates the secretion of pp69, suggesting its relationship with 
cellular proliferation. Antibody raised against pp69 recognizes, inaddition to pp69, another major phospho- 
protein of 62 kDa (pp62) secreted by RR1022 and spontaneously transformed NRK-49F cells. Immunopre- 
cipitation of total cell lysates from both NRK-49F and RR1022 cells with anti-pp69 antibody detected only 
pp69. These observations suggest a precursor-product relationship between pp69 secreted by non-trans- 
formed NRK-49F cells and pp62 secreted by transformed cells. 
Phosphoprotein pp69; Epidermal growth factor; Transforming rowth factor fl; Phosphoprotein; Protein secretion; 
(NRK-49F cell) 
1. INTRODUCTION 
Mammalian fibroblast cells in culture secrete in- 
to their extracellular environment a wide variety of 
proteins [1], including a few major phosphopro- 
teins [2-4]. One of these phosphoproteins i  a 
polypeptide of approx. 62 kDa, which has been 
shown to be associated with cell transformation 
[5]. We have previously reported that non- 
transformed normal rat kidney (NRK-49F) 
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fibroblasts, as well as retinoic acid-treated RR1022 
and SR-1T cells which reversibly acquire non- 
transformed phenotype, predominantly secrete a 
non-glycosylated 69 kDa phosphoprotein (pp69) 
[6]. Here we show that pp69 secretion by NRK-49F 
cells is modulated upon treatment with EGF and 
TGF-B. In addition, our data show that pp69 is im- 
munologically related to a 62 kDa phosphoprotein 
secreted by many transformed cells. 
2. MATERIALS AND METHODS 
NRK-49F and RR1022 cells were obtained from 
the American Type Culture Collection (ATCC, 
Rockville, MD). All cells were grown in DMEM 
(Gibco) supplemented with 10070 NCS. Cells were 
re-fed daily and passaged 24-48 h prior to la- 
beling. Monolayers were incubated with either 
phosphate- or methionine-free medium with or 
without growth factors for 1 h before incubation 
for 4 h in 0.75 or 1 ml growth medium containing 
0.5-1.0°7o serum and 0.13 mCi/ml of 
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00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 261 
Volume 222, number 2 FEBS LETTERS October 1987 
[35S]methionine or 0.5 mCi/ml of [32p]or- 
thophosphate (Amersham). EGF (Sigma) and/or 
TGF-• (a gift from Dr Anita Roberts, NIH, 
Bethesda) were used at a final concentration f 5 
or 50 ng/ml and 0.1 or 1 ng/ml, respectively. 
For the analysis of secreted proteins, condition- 
ed medium was removed and centrifuged in an Ep- 
pendorf microfuge for 3 min. 100-/A aliquots were 
taken and precipitated with 4 vols cold acetone 
and pelleted by centrifugation. The pellet was 
washed with a small volume of cold acetone, dried, 
solubilized in 50/A sample buffer (0.07 M Tris- 
HCI, pH 6.8, 10%0 glycerol, 5% ~'- 
mercaptoethanol, 3% SDS, 0.01% bromophenol), 
and samples containing equal cpm were applied to 
7.5 or 10% SDS-PAGE gels and analyzed [7]. Gels 
containing [35S]methionine-labeled samples were 
soaked for 30 min in 1 M sodium salicylate [8], 
rinsed, dried and exposed to Fuji-RX X-ray film at 
-70°C. Two-dimensional nalyses of secreted 
proteins were carried out according to O'Farrell 
[91. 
Phosphoamino acid analysis was done either by 
using 32p-labeled proteins from gel slices, or from 
acetone-precipitated conditioned media. Proteins 
were hydrolyzed in 6 N HCI at 110°C for 1 h and 
the hydrolysates were resuspended in small 
volumes of distilled water, mixed with unlabeled 
phosphoamino acids, and then separated either by 
ascending thin-layer chromatography using 
0.05 M NH4OH :isobutyric acid (5:3, v/v) or by 
high-voltage lectrophoresis n pyridine, acetic 
acid and water 1 : 10:189 [9]. 
Antibody directed against pp69 was prepared us- 
ing concentrated conditioned medium or pp69 
eluted from gel slices; samples were mixed with 
Freund's adjuvant and injected into rabbits as 
described [5]. 
3. RESULTS AND DISCUSSION 
Non-transformed NRK-49F cells, characterized 
by their inability to grow in soft agar [11], and the 
lack of phosphorylation of a group of low- 
molecular-mass membrane proteins [12], secrete a
major phosphoprotein of 69 kDa (pp69) 
(fig.lA,B, lanes 1). Densitometric tracings of the 
audioradiograms revealed that treatment of 
NRK-49F cells with 5 ng/ml of EGF, which was 
found to be mitogenic for these cells [13], caused 
an approx. 3-fold increase in the levels of 32p_ 
labeled pp69 (fig.lA, lane 4), as compared to un- 
Fig.l. Analysis of 32p-labeled secreted pp69 by SDS-PAGE. (A,B) Acetone-precipitated s creted proteins; (C) 
immunoprecipitated s creted proteins and total cell lysates. All treatments were for 96 h. (A) Lanes: (1) NRK-49F 
untreated, (2) 1 ng/ml TGF-B, (3) 1 ng/ml TGF-/~ plus 5 ng/ml EGF, (4) 5 ng/ml EGF. (B) Lanes: (1) NRK-49F 
untreated, (2) 0.1 ng/ml TGF-ff, (3) 0.1 ng/ml TGF-ff plus 5 ng/ml EGF. (C) Lanes: (1) NRK-49F untreated, (2) 
0.1 ng/ml of TGF-ff plus 5 ng/ml EGF, (3) 0.1 ng/ml TGF-/~ plus 50 ng/ml EGF, (4) RRI022 cells, (5) normal rabbit 
serum, (6) total NRK-49F cell lysate, (7) total RRI022 cell lysate. 
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treated cells. On the other hand, TGF-~, a known 
inhibitor of cell proliferation [14], at 0.1 and 
1 ng/ml caused a 2- and 4-fold decrease respective- 
ly, of 32p-labeled pp69 (fig. 1A,B, lanes 2) relative 
to levels observed for untreated cells. 
This putative growth-related modulation of the 
levels of 32p-labeled pp69 was further tested by 
treating NRK-49F cells with both TGF-~ and EGF. 
Simultaneous treatment with 0.1 ng/ml of TGF-~ 
plus 5.0 ng/ml of EGF, which induced colony for- 
mation of NRK-49F cells in soft agar (not shown), 
caused a 3-fold increase in the levels of 32p-labeled 
pp69 (fig.lB, lane 3) as compared to untreated 
cells. When the concentration of TGF-~ was in- 
creased 10-fold (1.0 ng/ml) but the EGF concen- 
tration remained the same (5.0 ng/ml), an 18-fold 
decrease in 32p-labeled pp69 was observed (fig. 1A, 
lane 3). These observations were further confirmed 
by immunoprecipitation f 32p-labeled secreted 
proteins with a polyclonal anti-pp69 rabbit an- 
tibody (fig.lC). Phosphoamino acid analysis of 
pp69 secreted by both untreated and EGF plus 
TGF-B-treated NRK-49F cells as well as of pp62 
secreted by RR1022 and KNRK cells revealed that 
only serine residues are phosphorylated (not 
shown). 
Immunoprecipitation f secreted phosphopro- 
tein from RR1022 cells with anti-pp69 antibody 
showed two major phosphoprotein bands, one of 
69 kDa (pp69) and the other of 62 kDa (pp62) 
(fig.lC, lane 4). This lower molecular mass 
phosphoprotein has been shown to be a specific 
marker for most transformed cells [5,6,15]. It 
is apparent, therefore, that the 62 kDa 
transformation-associated phosphoprotein s im- 
munologically related to pp69. Peptide mapping of 
partially digested pp69 and pp62 with V8 protease, 
carried out in our previous study, showed con- 
siderable fragment homology [6]. Immuno- 
precipitation of 32P-labeled total cell lysates from 
both non-transformed NRK-49F and transformed 
RR1022 cells showed only pp69 (fig.lC, lanes 6 
and 7, respectively). 
To determine whether the increased levels of 
32p-labeled pp69 found in the conditioned media 
of EGF and TGF-B treated cells were due to in- 
creased secretion of phosphorylation of this pro- 
tein, secreted proteins were labeled with 
[35S]methionine and analyzed (fig.2A). It can be 
seen that treatments of NRK-49F cells with 
Fig.2. Analysis of [35S]methionine-labeled secreted pp69 
by SDS-PAGE. (A) Acetone-precipitated secreted 
proteins; (B) immunoprecipitated secreted proteins. All 
treatments were for 96 h. (A) Lanes: (l) 50 ng/ml EGF, 
(2) 0.1 ng/ml TGF-~ plus 50 ng/ml EGF, (3) 0.1 ng/ml 
TGF-B plus 5 ng/ml EGF, (4) 0.1 ng/ml TGF-B, (5) 
NRK-49F untreated. (B) Lanes: (1) NRK-49F untreated, 
(2) 0.1 ng/ml TGF-~' plus 5 ng/ml EGF, (3) 0.1 ng/ml 
TGF-~' plus 50 ng/ml EGF. 
50 ng/ml of EGF, 0.1 ng/ml TGF-B plus 50 ng/ml 
of EGF, and 0.1 ng/ml of TGF-/~ plus 5 ng/ml of 
EGF, showed significant increase in the amount of 
labeled pp69 (fig.2A, lanes 1-3, respectively). 
Treatment of NRK-49F cells with 0.1 ng/ml of 
TGF-~ alone caused a slight decrease in radioac- 
tivity associated with pp69 (fig.2A, lane 4) as com- 
pared to untreated cells (lane 5). Immuno- 
precipitation of [35S]methionine-labeled pp69 with 
an anti-pp69 antibody confirmed that treatment of 
NRK-49F cells with EGF and TGF-/~ significantly 
increases the secretion of pp69 (fig.2B). These 
observations suggest hat EGF and TGF-treated 
cells secrete more pp69 than their untreated 
counterparts. 
Since EGF treatment alone caused increased 
secretion of pp69 by NRK-49F cells (fig.2A, lane 
1), we determined the length of EGF treatment 
needed for such an increase. Initially, long- and 
short-term treatments were carried out. Treatment 
of NRK-49F cells with EGF for 48, 96 and 120 h 
significantly increased the secretion of pp69 
(fig.3A, lanes 3-5). A 4 h EGF treatment did not 
263 
Volume 222, number 2 FEBS LETTERS October 1987 
A 
6 
7 8 9 10 
B 
I e l  ~ ° / 
S=2 
C 
I~OI1115 
0 4 6 12 24 48 
Fig.3. Time-course study of the effects of EGF treatment (50 ng/ml) on the secretion of pp69 by NRK-49F cells. (A) 
Lanes 1-5, acetone-precipitated s creted proteins; 6-10, immunoprecipitated s creted proteins. Lanes: (1) 0 h, (2) 4 h, 
(3) 48 h, (4) 96 h, (5) 120 h, (M) markers, (6) 0 h, (7) 4 h, (8) 48 h, (9) 96 h, (10) 120 h. (B) Radioactivity (cpm) present 
in pp69 band from samples taken at various time points after EGF treatment. (C) Typical SDS-PAGE pattern of 
immunoprecipitated pp69 taken at various time points after EGF treatment. The numbers under each band represent 
hours of EGF treatment. Arrows indicate the position of pp69. 
Fig.4. Two-dimensional gel analysis of [35S]methionine (A,B) and [~ZP]orthophosphate (C,D) secreted proteins; (A,C) 
NRK-49F untreated, (B,D) 0.1 ng/ml TGF-~' plus 5 ng/ml EGF. Small arrow indicates pp69 and large arrowhead 
denotes the non-phosphorylated 69 kDa protein. 
increase section of pp69 (fig.3A, lane 2). Analysis 
of immunoprecipitated pp69 confirmed the above 
results (lanes 6-10). In order to determine the ex- 
act length of EGF treatment needed for the in- 
creased secretion of pp69, the time course study 
was extended to include time points between 4 and 
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48 h. As can be seen in fig.3B and C, a significant 
increase in levels of pp69 could be detected be- 
tween 4 and 6 h of EGF treatment, and a maximal 
level was reached at approx. 48 h. Estimation of 
radioactivity in pp69 bands taken from four gels 
resulting from two separate xperiments confirmed 
the above observation (fig.3B). 
Two-dimensional electrophoretic analysis of 
[35S]methionine-labeled s creted proteins demon- 
strated that two distinct 69 kDa proteins are ex- 
creted by NRK-49F cells; the phosphorylated form 
(pp69) which has a pI of approx. 6.0, and a more 
acidic non-phosphorylated protein (np69) (fig.4). 
Secretion of both of these proteins was increased 
upon treatment with 5 ng/ml of EGF plus 0.1 
ng/ml of TGF-fl. 
Following prolonged culture of NRK-49F cells, 
a proportion of the cell population undergoes 
spontaneous transformation. As a result, signifi- 
cant levels of pp62 could be detected in the condi- 
tioned media of these cultures (fig.5, lane 1). It is 
clear, therefore, that the secretion of pp69 can be 
used as a specific marker for non-transformed 
NRK-49F cells. Treatment of NRK-49F cultures 
containing spontaneously transformed cells with 
Fig.5. Analysis of immunoprecipitated 32p-labeled 
secreted proteins from partially transformed NRK-49F 
cultures and RRI022 cells. Lanes: (1) NRK-49F 
untreated, (2) 0.1 ng/ml TGF-fl plus 5 ng/ml EGF, (3) 
1 ng/ml TGF-fl plus 5 ng/ml EGF, (4) RRI022, acetone- 
precipitated control. 
5 ng/ml EGF plus 0.1 ng/ml of TGF-fl caused an 
increase in the amount of both 32p-labeled pp69 
and pp62 (lane 2). When these cultures were 
treated with 1 ng/ml of TGF-~ plus 5 ng/ml EGF, 
the level of radioactivity in the pp69 band 
significantly decreased, and pp62 was undetectable 
(lane 3). These results show that EGF and TGF-~? 
modulate the secretion of both pp69 and pp62. 
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